Explore

Trendline Trendline
Frontier Medicines Appoints David R. Epstein to Board to Drive Drug Development

Frontier Medicines Appoints David R. Epstein to Board to Drive Drug Development

Frontier Medicines Appoints David R. Epstein to Board to Drive Drug Development
Trendline Trendline
Frontier Medicines Appoints David R. Epstein to Board of Directors to Drive Growth

Frontier Medicines Appoints David R. Epstein to Board of Directors to Drive Growth

Frontier Medicines Appoints David R. Epstein to Board of Directors to Drive Growth
Trendline Trendline
Frontier Medicines Appoints David R. Epstein to Board Amid Precision Medicine Expansion

Frontier Medicines Appoints David R. Epstein to Board Amid Precision Medicine Expansion

Frontier Medicines Appoints David R. Epstein to Board Amid Precision Medicine Expansion
Trendline Trendline
4D Path and Daiichi Sankyo Collaborate on AI-Driven Biomarkers for Cancer Treatment

4D Path and Daiichi Sankyo Collaborate on AI-Driven Biomarkers for Cancer Treatment

4D Path and Daiichi Sankyo Collaborate on AI-Driven Biomarkers for Cancer Treatment
Trendline Trendline
Eli Lilly Acquires CrossBridge Bio to Enhance Antibody-Drug Conjugate Development

Eli Lilly Acquires CrossBridge Bio to Enhance Antibody-Drug Conjugate Development

Eli Lilly Acquires CrossBridge Bio to Enhance Antibody-Drug Conjugate Development
Trendline Trendline
Parabilis Medicines Expands Leadership Team to Drive Cancer Drug Development

Parabilis Medicines Expands Leadership Team to Drive Cancer Drug Development

Parabilis Medicines Expands Leadership Team to Drive Cancer Drug Development
Trendline Trendline
Kivu Bioscience Appoints Mohit Trikha as CEO to Drive Oncology Advancements

Kivu Bioscience Appoints Mohit Trikha as CEO to Drive Oncology Advancements

Kivu Bioscience Appoints Mohit Trikha as CEO to Drive Oncology Advancements
Trendline Trendline
Kivu Bioscience Names Mohit Trikha as CEO to Drive Oncology Innovations

Kivu Bioscience Names Mohit Trikha as CEO to Drive Oncology Innovations

Kivu Bioscience Names Mohit Trikha as CEO to Drive Oncology Innovations
Trendline Trendline
4D Path and Daiichi Sankyo Collaborate on AI Biomarkers for Cancer Treatment

4D Path and Daiichi Sankyo Collaborate on AI Biomarkers for Cancer Treatment

4D Path and Daiichi Sankyo Collaborate on AI Biomarkers for Cancer Treatment
Trendline Trendline
IDEAYA and Servier's PKC Drug Shows Promise in Uveal Melanoma Trial

IDEAYA and Servier's PKC Drug Shows Promise in Uveal Melanoma Trial

IDEAYA and Servier's PKC Drug Shows Promise in Uveal Melanoma Trial
Trendline Trendline
Eli Lilly Acquires CrossBridge Bio, Enhancing Cancer Treatment Capabilities

Eli Lilly Acquires CrossBridge Bio, Enhancing Cancer Treatment Capabilities

Eli Lilly Acquires CrossBridge Bio, Enhancing Cancer Treatment Capabilities
Trendline Trendline
Novigenix AI Presents Breakthrough in Immuno-Pharmacodynamics at AACR 2026

Novigenix AI Presents Breakthrough in Immuno-Pharmacodynamics at AACR 2026

Novigenix AI Presents Breakthrough in Immuno-Pharmacodynamics at AACR 2026